1,121
Views
126
CrossRef citations to date
0
Altmetric
Liver and biliary tract

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands

, , , , , , , , , , , , , , , , , , , , , & show all
Pages 1245-1254 | Received 11 May 2014, Accepted 11 Jul 2014, Published online: 15 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Åsa Danielsson Borssén, Hanns-Ulrich Marschall, Annika Bergquist, Fredrik Rorsman, Ola Weiland, Stergios Kechagias, Nils Nyhlin, Hans Verbaan, Emma Nilsson & Mårten Werner. (2017) Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis. Scandinavian Journal of Gastroenterology 52:9, pages 1022-1028.
Read now

Articles from other publishers (125)

Zhou Yuming, Tang Ruqi, Merrill Eric Gershwin & Ma Xiong. (2024) Autoimmune Hepatitis. Clinics in Liver Disease 28:1, pages 15-35.
Crossref
Mitchell L. Shiffman. (2024) Autoimmune Hepatitis. Clinics in Liver Disease 28:1, pages 1-14.
Crossref
Raul S. Gonzalez, Kay Washington & Ansgar W. Lohse. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver 527 555 .
Clarisse de Almeida Gallo, Alessandra Dellavance, Raimundo Araújo Gama, Antônio Eduardo Silva, Ivonete Sandra de Souza e Silva, Luis Eduardo Coelho Andrade & Maria Lúcia Gomez Ferraz. (2023) Anti-ribosomal P (anti-P) antibodies in patients with autoimmune hepatitis. einstein (São Paulo) 21.
Crossref
Nikolai I. Kuznetsov, Valery V. Vasiliev, Elena S. Romanova, Galina Yu. Startseva, Ivan P. Fedunyak, Vladimir B. Musatov & Alexander М. Alekseev. (2023) Acute iucterine hepatitis as a manifestation of severe autoimmune hepatitis. Russian Family Doctor 27:3, pages 55-61.
Crossref
Jong Woo Hahn, Hye Ran Yang, Jin Soo Moon, Ju Young Chang, Kwanjoo Lee, Gi Ae Kim, Masoud Rahmati, Ai Koyanagi, Lee Smith, Min Seo Kim, Guillermo F. López Sánchez, Dragioti Elena, Ju-Young Shin, Jae Il Shin, Rosie Kwon, Soeun Kim, Hyeon Jin Kim, Hojae Lee, Jae Sung Ko & Dong Keon Yon. (2023) Global incidence and prevalence of autoimmune hepatitis, 1970–2022: a systematic review and meta-analysis. eClinicalMedicine 65, pages 102280.
Crossref
Raúl J. Andrade, Guruprasad P. Aithal, Ynto S. de Boer, Rodrigo Liberal, Alexander Gerbes, Arie Regev, Benedetta Terziroli Beretta-Piccoli, Christoph Schramm, David E. Kleiner, Eleonora De Martin, Gerd A. Kullak-Ublick, Guido Stirnimann, Harshad Devarbhavi, John M. Vierling, Michael P. Manns, Marcial Sebode, Maria Carlota Londoño, Mark Avigan, Mercedes Robles-Diaz, Miren García-Cortes, Edmond Atallah, Michael Heneghan, Naga Chalasani, Palak J. Trivedi, Paul H. Hayashi, Richard Taubert, Robert J. Fontana, Sabine Weber, Ye Htun Oo, Yoh Zen, Anna Licata, M Isabel Lucena, Giorgina Mieli-Vergani, Diego Vergani & Einar S. Björnsson. (2023) Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report. Journal of Hepatology 79:3, pages 853-866.
Crossref
Vikas Yadav, Rabbia Irfan, Shamayel Safdar, Vyshnavidevi Sunkara, Chukwuyem Ekhator, Praful R Pendyala, Monika Devi, S M Iram Shahzed, Archana Das, Maryam Affaf, Sophia B Bellegarde, Riya Shrestha, Muhammad Arsal Naseem & Ahmed Al Khalifa. (2023) Advances in Understanding and Managing Autoimmune Hepatitis: A Narrative Review. Cureus.
Crossref
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, Yvonne Ayerki Nartey, Elisa Pose & Patrick S. Kamath. (2023) Global burden of liver disease: 2023 update. Journal of Hepatology 79:2, pages 516-537.
Crossref
Jan Philipp Weltzsch, Annerose Ziegler & Ansgar Lohse. (2023) Autoimmune HepatitisAutoimmune hepatitis. Die Innere Medizin 64:7, pages 655-667.
Crossref
Liping Li & Yongbo Kang. (2023) The Gut Microbiome and Autoimmune Hepatitis: Implications for Early Diagnostic Biomarkers and Novel Therapies. Molecular Nutrition & Food Research.
Crossref
Matthias Buechter, Dominik Dorn, Birte Möhlendick, Winfried Siffert, Hideo A. Baba, Guido Gerken & Alisan Kahraman. (2023) Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center. Journal of Clinical Medicine 12:13, pages 4192.
Crossref
Wei He, Qi Wei Qian, Qiao Yan Liu, Yi Kang Li, Qi Miao, Qi Xia Wang, Xiong Ma, Zheng Rui You & Ru Qi Tang. (2023) IL ‐26 modulates T cell function in autoimmune hepatitis . Journal of Digestive Diseases.
Crossref
Hui Liu, Yuqi Wang, Peng Wang, Xin Wang, Yunyun Yi & Xin Li. (2023) Clinical significance of serum antinuclear antibodies in patients with autoimmune hepatitis and comorbidity. Clinical and Experimental Medicine 23:7, pages 3453-3463.
Crossref
Susan E. Fischer, Elsemieke S. de Vries, Maarten E. Tushuizen, Ynto S. de Boer, Adriaan J. P. van der Meer, Robert A. de Man, Johannes T. Brouwer, Johan P. Kuyvenhoven, Michael Klemt‐Kropp, Tom J. G. Gevers, Eric T. T. L. Tjwa, Edith M. M. Kuiper, Marc A. M. T. Verhagen, Philip W. Friederich & Bart van Hoek. (2023) Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis. Liver International 43:4, pages 855-864.
Crossref
C.E. Lombo-Moreno, O.M. Muñoz-Velandia, D.G. Fernández-Ávila, J.E. Barahona-Correa, H.C. Aranguren & F.A. Avila. (2023) YouTube® en español como fuente de información para pacientes con hepatitis autoinmune. Revista de Gastroenterología de México.
Crossref
Albert J. Czaja. (2022) Missing Causality and Heritability of Autoimmune Hepatitis. Digestive Diseases and Sciences 68:4, pages 1585-1604.
Crossref
Kumar Subramanian, Saikat Paul, Andrew Libby, Jordan Patterson, Adam Arterbery, James Knight, Christopher Castaldi, Guilin Wang, Yaron Avitzur, Mercedes Martinez, Steve Lobritto, Yanhong Deng, Gan Geliang, Alexander Kroemer, Thomas Fishbein, Andrew Mason, Margarita Dominguez-Villar, Malaiyalam Mariappan & Udeme D. Ekong. (2023) HERV1-env Induces Unfolded Protein Response Activation in Autoimmune Liver Disease: A Potential Mechanism for Regulatory T Cell Dysfunction. The Journal of Immunology 210:6, pages 732-744.
Crossref
Therese Bittermann, James D. Lewis, Cynthia Levy & David S. Goldberg. (2023) Sociodemographic and geographic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis. Hepatology 77:2, pages 367-378.
Crossref
Romée J. A. L. M. Snijders, Anna E. C. Stoelinga, Tom J. G. Gevers, Simon Pape, Maaike Biewenga, Robert C. Verdonk, Hendrik J. M. de Jonge, Jan Maarten Vrolijk, Sjoerd F. Bakker, Thomas Vanwolleghem, Ynto S. de Boer, Martine A. M. C. Baven Pronk, Ulrich H. W. Beuers, Adriaan J. van der Meer, Nicole M. F. van Gerven, Marijn G. M. Sijtsma, Bart J. Verwer, Ingrid A. M. Gisbertz, Maartje Bartelink, Floris F. van den Brand, Kerem Sebib Korkmaz, Aad P. van den Berg, Maureen M. J. Guichelaar, Khalida Soufidi, Amar D. Levens, Bart van Hoek & Joost P. H. Drenth. (2022) Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial. Trials 23:1.
Crossref
Tian Fu, Yifei Chen, Junkui Li, Peili Zhu, Huajuan He, Wei Zhang, Ken Kin Lam Yung & Wei Wu. (2022) Exploring the Effective Components and Mechanism of Action of Japanese Ardisia in the Treatment of Autoimmune Hepatitis Based on Network Pharmacology and Experimental Verification. Pharmaceuticals 15:12, pages 1457.
Crossref
Silja Steinmann, Ida Schregel & Christoph Schramm. (2022) Autoimmune Lebererkrankungen – ein Update (Teil 1). Gastroenterologie up2date 18:03, pages 225-241.
Crossref
Tomohiro Katsumi & Yoshiyuki Ueno. (2022) Epidemiology and surveillance of autoimmune hepatitis in Asia. Liver International 42:9, pages 2015-2022.
Crossref
Albert J. Czaja. (2022) Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Frontiers in Immunology 13.
Crossref
Federica Invernizzi, Marta Cilla, Silvia Trapani, Maria Guarino, Valentina Cossiga, Martina Gambato, Maria Cristina Morelli, Filomena Morisco, Patrizia Burra & Annarosa Floreani. (2022) Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice. Journal of Personalized Medicine 12:6, pages 925.
Crossref
Jan‐Luca Reichardt, Meike Dirks, Ann‐Katrin Wirries, Henning Pflugrad, Patrick Nösel, Kim Haag, Heinrich Lanfermann, Heiner Wedemeyer, Andrej Potthoff, Karin Weissenborn & Xiao‐Qi Ding. (2021) Brain metabolic and microstructural alterations associated with hepatitis C virus infection, autoimmune hepatitis and primary biliary cholangitis. Liver International 42:4, pages 842-852.
Crossref
Nelgin GERENLİ & Coşkun ÇELTİK. (2022) Mode of Presentation and Associated Autoimmune Diseases in Children with Autoimmune HepatitisOTOİMMÜN HEPATİT TANILI ÇOCUKLARDA BAŞVURU ŞEKLİ VE EŞLİK EDEN OTOİMMÜN HASTALIK VARLIĞI. Genel Tıp Dergisi 32:1, pages 95-101.
Crossref
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani & Diego Vergani. (2021) Autoimmmune hepatitis. Cellular & Molecular Immunology 19:2, pages 158-176.
Crossref
Michael Torbenson, Sanjay Kakar & Kay Washington. 2022. Non-Neoplastic Diseases of the Liver. Non-Neoplastic Diseases of the Liver 149 175 .
Connie W. Wang, Joshua Grab, Michele M. Tana, Roxanna A. Irani & Monika Sarkar. (2021) Outcomes of pregnancy in autoimmune hepatitis: A population‐based study. Hepatology 75:1, pages 5-12.
Crossref
Claudia Sirbe, Gelu Simu, Iulia Szabo, Alina Grama & Tudor Lucian Pop. (2021) Pathogenesis of Autoimmune Hepatitis—Cellular and Molecular Mechanisms. International Journal of Molecular Sciences 22:24, pages 13578.
Crossref
Gwilym J. Webb, Ronan P. Ryan, Tom P. Marshall & Gideon M. Hirschfield. (2021) The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude. Clinical Gastroenterology and Hepatology 19:12, pages 2587-2596.
Crossref
Nahel A. Tunio, Emad Mansoor, Mohammed Z. Sheriff, Gregory S. Cooper, Seth N. Sclair & Stanley M. Cohen. (2021) Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019. Journal of Clinical Gastroenterology 55:10, pages 903-910.
Crossref
Tania Franceschini, Francesco Vasuri, Paolo Muratori, Luigi Muratori, Maria Guido, Marco Lenzi & Antonia D’Errico. (2021) A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center. Virchows Archiv 479:5, pages 937-945.
Crossref
Palak J Trivedi & Gideon M Hirschfield. (2021) Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 70:10, pages 1989-2003.
Crossref
Maurice Michel, Francesca Spinelli, Annette Grambihler, Christian Labenz, Michael Nagel, Leonard Kaps, Yvonne Huber, Peter R. Galle, Marcus-Alexander Wörns & Jörn M. Schattenberg. (2021) Health-related quality of life in patients with autoimmune hepatitis. Quality of Life Research 30:10, pages 2853-2861.
Crossref
Bastian Engel, Alena Laschtowitz, Maciej K. Janik, Norman Junge, Ulrich Baumann, Piotr Milkiewicz, Richard Taubert & Marcial Sebode. (2021) Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. European Journal of Medical Genetics 64:6, pages 104214.
Crossref
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata & Shiv Kumar Sarin. (2021) The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 15:2, pages 223-257.
Crossref
Eirini I. Rigopoulou & George N. Dalekos. (2021) Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers 13:5, pages 1023.
Crossref
Mehul Lamba, Jing Hieng Ngu & Catherine A.M. Stedman. (2021) Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 19:3, pages 573-579.e1.
Crossref
Takashi Higuchi, Shomi Oka, Hiroshi Furukawa, Shigeto Tohma, Hiroshi Yatsuhashi & Kiyoshi Migita. (2021) Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response. Human Genomics 15:1.
Crossref
Sanchit Sharma, Samagra Agarwal, Kanav Kaushal, Abhinav Anand, Deepak Gunjan, Rajni Yadav & Anoop Saraya. (2020) Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids. JGH Open 5:1, pages 81-90.
Crossref
Renata S FEDRIZZI, Gabriela P CORAL, Angelo A de MATTOS, Ângelo Z de MATTOS & Cristiane V TOVO. (2020) EVALUATION OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN A SPECIALIZED OUTPATIENT CLINIC IN SOUTHERN BRAZIL. Arquivos de Gastroenterologia 57:4, pages 361-365.
Crossref
Maaike Biewenga, Akin Inderson, Maarten E. Tushuizen, A. Stijn L.P. Crobach & Bart van Hoek. (2020) Early Predictors of Short‐Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis. Liver Transplantation 26:12, pages 1573-1581.
Crossref
Simon Pape, Tom J. G. Gevers, Jan Maarten Vrolijk, Bart van Hoek, Gerd Bouma, Carin M. J. van Nieuwkerk, Richard Taubert, Elmar Jaeckel, Michael P. Manns, Maria Papp, Nora Sipeki, Felix Stickel, Cumali Efe, Ersan Ozaslan, Tugrul Purnak, Frederik Nevens, Dominik J. N. Kessener, Alisan Kahraman, Heiner Wedemeyer, Johannes Hartl, Christoph Schramm, Ansgar W. Lohse, Michael A. Heneghan & Joost P. H. Drenth. (2020) High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation. Liver International 40:9, pages 2164-2171.
Crossref
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad & Albert J. Czaja. (2020) Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 72:2, pages 671-722.
Crossref
Naomi Richardson, Sky T. H. Ng & David C. Wraith. (2020) Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases. Frontiers in Immunology 11.
Crossref
Atsushi Tanaka. (2020) Autoimmune Hepatitis: 2019 Update. Gut and Liver 14:4, pages 430-438.
Crossref
Lisbet Grønbæk, Harmony Otete, Lu Ban, Colin Crooks, Timothy Card, Peter Jepsen & Joe West. (2020) Incidence, prevalence and mortality of autoimmune hepatitis in England 1997‐2015. A population‐based cohort study. Liver International 40:7, pages 1634-1644.
Crossref
Simon Pape, Frederik Nevens, Chris Verslype, Caroline Mertens, Joost P.H. Drenth & Eric T.T.L. Tjwa. (2020) Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience. European Journal of Gastroenterology & Hepatology 32:6, pages 727-732.
Crossref
Johannes Hartl, Rosa Miquel, Kalliopi Zachou, Guan-Wee Wong, Asma Asghar, Simon Pape, Marcial Sebode, Moritz Peiseler, Roman Zenouzi, Hanno Ehlken, Till Krech, Christina Weiler-Normann, Joost P.H. Drenth, Ye H. Oo, George Nikolaos Dalekos, Michael Heneghan, Christoph Schramm & Ansgar Wilhelm Lohse. (2020) Features and outcome of AIH patients without elevation of IgG. JHEP Reports 2:3, pages 100094.
Crossref
Maaike Biewenga, Arantza Farina Sarasqueta, Maarten E. Tushuizen, Eveline S.M. de Jonge-Muller, Bart van Hoek & Leendert A. Trouw. (2020) The role of complement activation in autoimmune liver disease. Autoimmunity Reviews 19:6, pages 102534.
Crossref
Yi Wang, Yanni Li, Xiaoyi Wang, Ranko Gacesa, Jie Zhang, Lu Zhou & Bangmao Wang. (2020) Predicting Liver Disease Risk Using a Combination of Common Clinical Markers: A Screening Model from Routine Health Check-Up. Disease Markers 2020, pages 1-11.
Crossref
Aliya Gulamhusein & Patrick McKiernan. 2020. Autoimmune Liver Disease. Autoimmune Liver Disease 103 122 .
Diego Vergani, Ian R. Mackay & Giorgina Mieli-Vergani. 2020. The Autoimmune Diseases. The Autoimmune Diseases 1117 1147 .
Rodrigo Liberal, Giorgina Mieli-Vergani & Diego Vergani. 2020. Liver Immunology. Liver Immunology 419 441 .
Zhuwan Lyu, M. Eric Gershwin & Xiong Ma. 2020. Liver Immunology. Liver Immunology 167 178 .
Paul A. Schmeltzer. 2020. Diagnosis and Management of Autoimmune Hepatitis. Diagnosis and Management of Autoimmune Hepatitis 93 108 .
Sean R. Rudnick. 2020. Diagnosis and Management of Autoimmune Hepatitis. Diagnosis and Management of Autoimmune Hepatitis 51 61 .
Christos Liaskos, George Efthymiou & Dimitrios P. Bogdanos. 2020. Liver Diseases. Liver Diseases 143 151 .
Kjartan B. Valgeirsson, Jóhann P. Hreinsson & Einar S. Björnsson. (2019) Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs. Liver International 39:12, pages 2341-2349.
Crossref
Chi Zhang, Shan-Shan Wu, Xiao-Qin Dong, Zhao Wu, Hong Zhao & Gui-Qiang Wang. (2019) The efficacy and safety of different doses of glucocorticoid for autoimmune hepatitis. Medicine 98:52, pages e18313.
Crossref
Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger & Thomas Berg. (2019) Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies. Journal of Immunology Research 2019, pages 1-19.
Crossref
Floris F. van den Brand, Koen S. van der Veen, Birgit I. Lissenberg‐Witte, Ynto S. de Boer, Bart van Hoek, Joost P. H. Drenth, Robert C. Verdonk, Jan M. Vrolijk, Carin M. J. van Nieuwkerk & Gerd Bouma. (2019) Adverse events related to low dose corticosteroids in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 50:10, pages 1120-1126.
Crossref
Tingting Lv, Min Li, Na Zeng, Jingqi Zhang, Shuxiang Li, Sha Chen, Chunpan Zhang, Shan Shan, Weijia Duan, Qianyi Wang, Shanshan Wu, Hong You, Xiaojuan Ou, Hong Ma, Dong Zhang, Yuanyuan Kong & Jidong Jia. (2019) Systematic review and meta‐analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. Journal of Gastroenterology and Hepatology 34:10, pages 1676-1684.
Crossref
Roongruedee Chaiteerakij, Anapat Sanpawat, Anchalee Avihingsanon & Sombat Treeprasertsuk. (2019) Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature. World Journal of Gastroenterology 25:35, pages 5388-5402.
Crossref
Lauri Puustinen, Nina Barner-Rasmussen, Eero Pukkala & Martti Färkkilä. (2019) Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland. Digestive and Liver Disease 51:9, pages 1294-1299.
Crossref
Simon Pape, Tom J.G. Gevers, Michail Belias, Ilyas F. Mustafajev, Jan Maarten Vrolijk, Bart van Hoek, Gerd Bouma, Carin M.J. van Nieuwkerk, Johannes Hartl, Christoph Schramm, Ansgar W. Lohse, Richard Taubert, Elmar Jaeckel, Michael P. Manns, Maria Papp, Felix Stickel, Michael A. Heneghan & Joost P.H. Drenth. (2019) Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 17:10, pages 2068-2075.e2.
Crossref
Atsushi Tanaka, Mitsuru Mori, Kosuke Matsumoto, Hiromasa Ohira, Susumu Tazuma & Hajime Takikawa. (2019) Increase trend in the prevalence and male‐to‐female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatology Research 49:8, pages 881-889.
Crossref
Ynto S. de Boer, Alessio Gerussi, Floris F. van den Brand, Guan-Wee Wong, Neil Halliday, Rodrigo Liberal, Joost P.H. Drenth, Douglas Thorburn, Gerd Bouma, Michael A. Heneghan, N.M. van Gerven, U. Beuers, K.J. van Erpecum, H.R. van Buuren, J.W. den Ouden, J.T. Brouwer, J.M. Vrolijk, R.C. Verdonk, B. van Hoek, G.H. Koek, M.M.J. Guichelaar, E. Bloemena, C.M.J. van Nieuwkerk, T.C.M.A. Schreuder, E.J. van der Wouden, J.J.M. van Meyel, L.C. Baak, P.H.G.M. Stadhouders, M. Klemt-Kropp, M.A.M.T. Verhagen, A. Bhalla & J.Ph. Kuijvenhoven. (2019) Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 17:8, pages 1616-1624.e2.
Crossref
Nanda Kerkar. (2019) Autoimmune Hepatitis in Special Populations: In Pediatrics and Across Different Ethnicities/Races. Clinical Liver Disease 14:1, pages 37-40.
Crossref
Lara Dakhoul, Keaton R. Jones, Samer Gawrieh, Marwan Ghabril, Chelsey McShane, Raj Vuppalanchi, Eduardo Vilar-Gomez, Lauren Nephew, Naga Chalasani & Craig Lammert. (2019) Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences 64:6, pages 1705-1710.
Crossref
Meike Dirks, Kim Haag, Henning Pflugrad, Anita B. Tryc, Ramona Schuppner, Heiner Wedemeyer, Andrej Potthoff, Hans L. Tillmann, Kajetan Sandorski, Hans Worthmann, Xiaoqi Ding & Karin Weissenborn. (2019) Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients. Journal of Viral Hepatitis 26:4, pages 422-431.
Crossref
Floris F. van den Brand, Koen S. van der Veen, Ynto S. de Boer, Nicole M. van Gerven, Birgit I. Lissenberg-Witte, Ulrich Beuers, Karel J. van Erpecum, Henk R. van Buuren, Jannie W. den Ouden, Johannus T. Brouwer, Jan M. Vrolijk, Robert C. Verdonk, Bart van Hoek, Ger H. Koek, Joost P.H. Drenth, Marleen M.J. Guichelaar, Chris J.J. Mulder, Elisabeth Bloemena, Carin M.J. van Nieuwkerk, Gerd Bouma, T.C.M.A. Schreuder, E.J. van der Wouden, J.J.M. van Meyel, L.C. Baak, P.H.G.M. Stadhouders, M. Klemt-Kropp, M.A.M.T. Verhagen, A. Bhalla & J.Ph. Kuijvenhoven. (2019) Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 17:5, pages 940-947.e2.
Crossref
Jessica K. Dyson, Eleonora De Martin, George N. Dalekos, Joost P.H. Drenth, Johannes Herkel, Stefan G. Hubscher, Deirdre Kelly, Marco Lenzi, Piotr Milkiewicz, Ye H. Oo, Michael A. Heneghan & Ansgar W. Lohse. (2019) Review article: unanswered clinical and research questions in autoimmune hepatitis‐conclusions of the International Autoimmune Hepatitis Group Research Workshop. Alimentary Pharmacology & Therapeutics 49:5, pages 528-536.
Crossref
Lisbet Grønbæk, Hendrik Vilstrup, Lars Pedersen & Peter Jepsen. (2018) Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study. Liver International 39:1, pages 205-214.
Crossref
Maciej K. Janik, Ewa Wunsch, Joanna Raszeja‐Wyszomirska, Maciej Moskwa, Beata Kruk, Marcin Krawczyk & Piotr Milkiewicz. (2018) Autoimmune hepatitis exerts a profound, negative effect on health‐related quality of life: A prospective, single‐centre study. Liver International 39:1, pages 215-221.
Crossref
Sumeet K. Asrani, Harshad Devarbhavi, John Eaton & Patrick S. Kamath. (2019) Burden of liver diseases in the world. Journal of Hepatology 70:1, pages 151-171.
Crossref
Tarek K. Motawi, Shohda A. El-Maraghy, Sahar A. Sharaf & Salma E. Said. (2019) Association of CARD10 rs6000782 and TNF rs1799724 variants with paediatric-onset autoimmune hepatitis. Journal of Advanced Research 15, pages 103-110.
Crossref
Giorgina Mieli-Vergani & Diego Vergani. 2019. Pediatric Hepatology and Liver Transplantation. Pediatric Hepatology and Liver Transplantation 175 199 .
Albert J. Czaja. 2019. Clinical Epidemiology of Chronic Liver Diseases. Clinical Epidemiology of Chronic Liver Diseases 251 305 .
Rachel Fogel, Megan Comerford, Prianka Chilukuri, Eric Orman, Naga Chalasani & Craig Lammert. (2018) Extrahepatic Autoimmune Diseases are Prevalent in Autoimmune Hepatitis Patients and Their First-Degree Relatives: Survey Study. Interactive Journal of Medical Research 7:2, pages e18.
Crossref
Amare Aregay, Meike Dirks, Verena Schlaphoff, Solomon Owusu Sekyere, Kim Haag, Christine Susanne Falk, Julia Hengst, Birgit Bremer, Ramona Schuppner, Michael P. Manns, Henning Pflugrad, Markus Cornberg, Heiner Wedemeyer & Karin Weissenborn. (2018) Systemic inflammation and immune cell phenotypes are associated with neuro‐psychiatric symptoms in patients with chronic inflammatory liver diseases. Liver International 38:12, pages 2317-2328.
Crossref
Jessica K. Dyson, Lin Lee Wong, Theophile Bigirumurame, Gideon M. Hirschfield, Stuart Kendrick, Ye H. Oo, Ansgar W Lohse, Michael A. Heneghan & David E. J. Jones. (2018) Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom. Alimentary Pharmacology & Therapeutics 48:9, pages 951-960.
Crossref
Floris F. van den Brand, Carin M. J. van Nieuwkerk, Bart J. Verwer, Ynto S. de Boer, Nanne K. H. de Boer, Chris J. J. Mulder, Elisabeth Bloemena, Christine M. Bakker, Jan M. Vrolijk, Joost P. H. Drenth, Adriaan C. I. T. L. Tan, Frank ter Borg, Martijn J. ter Borg, Sven J. van den Hazel, Akin Inderson, Maarten E. Tushuizen & Gerd Bouma. (2018) Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands. Alimentary Pharmacology & Therapeutics 48:7, pages 761-767.
Crossref
Lisbet Grønbæk, Hendrik Vilstrup, Lars Pedersen, Kaare Christensen & Peter Jepsen. (2018) Family occurrence of autoimmune hepatitis: A Danish nationwide registry-based cohort study. Journal of Hepatology 69:4, pages 873-877.
Crossref
Lin Lee Wong, Holly F Fisher, Deborah D Stocken, Stephen Rice, Amardeep Khanna, Michael A Heneghan, Ye Htun Oo, George Mells, Stuart Kendrick, Jessica Katharine Dyson & David E. J. Jones. (2018) The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility. Hepatology 68:4, pages 1487-1497.
Crossref
Victoria Gordon, Ratul Adhikary, Victoria Appleby, Debasis Das, James Day, Toby Delahooke, Selena Dixon, David Elphick, Claire Hardie, Barbara Hoeroldt, Patricia Hooper, John Hutchinson, Rebecca Jones, Faisal Khan, Guruprasad P. Aithal, John McGonigle, Andrew Nelson, Alick Nkhoma, Stavroula Pelitari, Martin Prince, Annell Prosser, Vinay Sathanarayana, Sophia Savva, Naina Shah, Sushma Saksena, Sreedhari Thayalasekaran, Deven Vani, Andrew Yeoman & Dermot Gleeson. (2018) Diagnosis, presentation and initial severity of Autoimmune Hepatitis ( AIH ) in patients attending 28 hospitals in the UK . Liver International 38:9, pages 1686-1695.
Crossref
Satoru Joshita, Kaname Yoshizawa, Takeji Umemura, Hiromasa Ohira, Atsushi Takahashi, Kenichi Harada, Nguyen Canh Hiep, Koichi Tsuneyama, Masayoshi Kage, Masayuki Nakano, Jong-Hon Kang, Kazuhiko Koike, Mikio Zeniya, Tetsuya Yasunaka, Akinobu Takaki, Takuji Torimura, Masanori Abe, Osamu Yokosuka, Atsushi Tanaka & Hajime Takikawa. (2018) Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey. Journal of Gastroenterology 53:9, pages 1079-1088.
Crossref
Albert Friedrich Stättermayer & Emina Halilbasic. (2018) Autoimmunhepatitis – Klinik, Diagnostik, TherapieAutoimmune hepatitis—clinical presentation, diagnosis, treatment. Journal für Gastroenterologische und Hepatologische Erkrankungen 16:2, pages 40-48.
Crossref
Arnaldo Freire & Cynthia Levy. (2018) Ethnic and Racial Differences in Autoimmune Liver Diseases. Current Hepatology Reports 17:2, pages 135-142.
Crossref
Giorgina Mieli-Vergani, Diego Vergani, Albert J. Czaja, Michael P. Manns, Edward L. Krawitt, John M. Vierling, Ansgar W. Lohse & Aldo J. Montano-Loza. (2018) Autoimmune hepatitis. Nature Reviews Disease Primers 4:1.
Crossref
David E.J. Jones, Ekkehard Sturm & Ansgar W. Lohse. (2018) Access to care in rare liver diseases: New challenges and new opportunities. Journal of Hepatology 68:3, pages 577-585.
Crossref
Sunil Taneja, Pramod Kumar, Suvradeep Mitra, Ajay Duseja, Ranjana Minz, Ashim Das, Radha K. Dhiman & Yogesh Chawla. (2018) Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis—A Case Series and Review of Literature. Journal of Clinical and Experimental Hepatology 8:1, pages 98-103.
Crossref
Carlo Selmi, Elena Generali & Merrill Eric Gershwin. (2018) Rheumatic Manifestations in Autoimmune Liver Disease. Rheumatic Disease Clinics of North America 44:1, pages 65-87.
Crossref
Gwilym James Webb, Abbas Rana, James Hodson, Mohammed Zeeshan Akhtar, James Walter Ferguson, James Max Neuberger, John Moore Vierling & Gideon Morris Hirschfield. (2018) Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists. Clinical Gastroenterology and Hepatology 16:2, pages 278-287.e7.
Crossref
G.J. WebbG.M. HirschfieldE.L. Krawitt & M.E. Gershwin. (2018) Cellular and Molecular Mechanisms of Autoimmune Hepatitis. Annual Review of Pathology: Mechanisms of Disease 13:1, pages 247-292.
Crossref
Megan Comerford, Rachel Fogel, James Robert Bailey, Prianka Chilukuri, Naga Chalasani & Craig Steven Lammert. (2018) Leveraging Social Networking Sites for an Autoimmune Hepatitis Genetic Repository: Pilot Study to Evaluate Feasibility. Journal of Medical Internet Research 20:1, pages e14.
Crossref
Kay Washington & Michael P. Manns. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver 491 514 .
Ansgar W. Lohse & Christina Weiler-Normann. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 594 609.e3 .
Benedetta Terziroli Beretta-Piccoli, Pietro Invernizzi, M. Eric Gershwin & Carlo Mainetti. (2017) Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review. Clinical Reviews in Allergy & Immunology 53:3, pages 394-412.
Crossref
A. J. Czaja. (2017) Review article: next‐generation transformative advances in the pathogenesis and management of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 46:10, pages 920-937.
Crossref
Gideon M. Hirschfield & Gwilym J. Webb. 2017. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver 546 562 .
Shizan Xu, Liwei Wu, Qinghui Zhang, Jiao Feng, Sainan Li, Jingjing Li, Tong Liu, Wenhui Mo, Wenwen Wang, Xiya Lu, Qiang Yu, Kan Chen, Yujing Xia, Jie Lu, Ling Xu, Yingqun Zhou, Xiaoming Fan & Chuanyong Guo. (2017) Pretreatment with propylene glycol alginate sodium sulfate ameliorated concanavalin A-induced liver injury by regulating the PI3K/Akt pathway in mice. Life Sciences 185, pages 103-113.
Crossref
Antonio Di Sabatino, Federico Biagi, Marco Lenzi, Luca Frulloni, Marco Vincenzo Lenti, Paolo Giuffrida & Gino Roberto Corazza. (2017) Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Digestive and Liver Disease 49:9, pages 947-956.
Crossref
Albert J. Czaja. (2017) Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Digestive Diseases and Sciences 62:9, pages 2277-2292.
Crossref
Bo Hyun Kim, Hwa Young Choi, Moran Ki, Kyung-Ah Kim, Eun Sun Jang & Sook-Hyang Jeong. (2017) Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea. PLOS ONE 12:8, pages e0182391.
Crossref
Aylin Tansel, Lior H. Katz, Hashem B. El-Serag, Aaron P. Thrift, Mayur Parepally, Mohammad H. Shakhatreh & Fasiha Kanwal. (2017) Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 15:8, pages 1207-1217.e4.
Crossref
Atsushi Takahashi, Teruko Arinaga-Hino, Hiromasa Ohira, Takuji Torimura, Mikio Zeniya, Masanori Abe, Kaname Yoshizawa, Akinobu Takaki, Yoshiyuki Suzuki, Jong-Hon Kang, Nobuhiro Nakamoto, Tomoo Fujisawa, Koji Yonemoto, Atsushi Tanaka & Hajime Takikawa. (2016) Autoimmune hepatitis in Japan: trends in a nationwide survey. Journal of Gastroenterology 52:5, pages 631-640.
Crossref
Guan‐Wee Wong, Tian Yeong, David Lawrence, Andrew D. Yeoman, Sumita Verma & Michael A. Heneghan. (2016) Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long‐term outcomes. Liver International 37:3, pages 449-457.
Crossref
Deepak Joshi, Nitika Gupta, Marianne Samyn, Maesha Deheragoda, Fabienne Dobbels & Michael A. Heneghan. (2017) The management of childhood liver diseases in adulthood. Journal of Hepatology 66:3, pages 631-644.
Crossref
A. S. Donker. 2017. Informatorium voor Voeding en Diëtetiek. Informatorium voor Voeding en Diëtetiek 57 100 .
A.D. Aravinthan, A.C. Doyle, A. Issachar, M. Dib, D. Peretz, M.S. Cattral, A. Ghanekar, I.D. McGilvray, M. Selzner, P.D. Greig, D.R. Grant, N. Selzner, L.B. Lilly & E.L. Renner. (2016) First-Degree Living-Related Donor Liver Transplantation in Autoimmune Liver Diseases. American Journal of Transplantation 16:12, pages 3512-3521.
Crossref
Kaname Yoshizawa, Satoru Joshita, Akihiro Matsumoto, Takeji Umemura, Eiji Tanaka, Susumu Morita, Toshitaka Maejima & Masao Ota. (2016) Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan. Hepatology Research 46:9, pages 878-883.
Crossref
Hong-Ying Pan, Yi-Ning Dai, Ji-Na Zheng, Ke-Qing Shi, Sven Van Poucke, Hai Zou & Ming-Hua Zheng. (2016) National incidence of autoimmune liver diseases and its relationship with the human development index. Oncotarget 7:29, pages 46273-46282.
Crossref
E. Fábrega, M.T. Arias-Loste, S. Llerena, P. Iruzubieta & J. Crespo García. (2016) Hepatitis autoinmune. Medicine - Programa de Formación Médica Continuada Acreditado 12:9, pages 494-504.
Crossref
Craig Lammert, Veronica M. Loy, Kiyoko Oshima & Samer Gawrieh. (2016) Management of Difficult Cases of Autoimmune Hepatitis. Current Gastroenterology Reports 18:2.
Crossref
Albert J Czaja. (2016) Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. World Journal of Gastroenterology 22:42, pages 9257.
Crossref
Nicole MF van Gerven, Ynto S de Boer, Chris JJ Mulder, Carin MJ van Nieuwkerk & Gerd Bouma. (2016) Auto immune hepatitis. World Journal of Gastroenterology 22:19, pages 4651.
Crossref
Qixia Wang, Fan Yang, Qi Miao, Edward L. Krawitt, M. Eric Gershwin & Xiong Ma. (2016) The clinical phenotypes of autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 66, pages 98-107.
Crossref
G.J. Webb & G.M. Hirschfield. (2016) Using GWAS to identify genetic predisposition in hepatic autoimmunity. Journal of Autoimmunity 66, pages 25-39.
Crossref
Carolina Jiménez-RiveraSimon C. LingNajma AhmedJason YapMary AglipayNick BarrowmanSamantha GraitsonJeff CritchMohsin RashidVicky L. NgEve A. RobertsHerbert BrillJenna K. DowhaniukGarth BruceKevin BaxMark DeneauOrlee R. GuttmanRichard A. SchreiberSteven Martin & Fernando Alvarez. (2015) Incidence and Characteristics of Autoimmune Hepatitis. Pediatrics 136:5, pages e1237-e1248.
Crossref
. (2015) EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 63:4, pages 971-1004.
Crossref
Albert J. Czaja. (2015) Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Digestive Diseases and Sciences 60:10, pages 2881-2900.
Crossref
N M F van Gerven, Y S de Boer, A Zwiers, B J Verwer, J P H Drenth, B van Hoek, K J van Erpecum, U Beuers, H R van Buuren, J W den Ouden, R C Verdonk, G H Koek, J T Brouwer, M M J Guichelaar, J M Vrolijk, M J Coenraad, G Kraal, C J J Mulder, C M J van Nieuwkerk, E Bloemena, H W Verspaget, V Kumar, A Zhernakova, C Wijmenga, L Franke & G Bouma. (2015) HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1. Genes & Immunity 16:4, pages 247-252.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.